Workflow
先进制造、芯片赛道投融资活跃,智谱AI获10亿元战略融资
2 1 Shi Ji Jing Ji Bao Dao·2025-07-08 09:00

Core Insights - The primary focus of the article is the resurgence of financing activities in advanced manufacturing, chips, and artificial intelligence sectors during the first week of July, indicating a recovery in the primary market [1]. Financing Activities - In the healthcare sector, Shanxi Jinbo Bio completed a strategic financing round of 34.03 billion RMB, backed by Yangshengtang, while Tianyan Pharmaceutical (Suzhou) secured 25 million USD from Sanofi [2][11][15]. - The technology and manufacturing sectors saw multiple financing rounds, with Beijing Zhipu Huazhang raising 1 billion RMB from Pudong Venture Capital Group and Zhangjiang Group [2][29]. - A total of 36 financing events were reported in the domestic primary market from June 30 to July 6, with 25 disclosing amounts totaling approximately 7.28 billion RMB [2][3]. Sector Distribution - The advanced manufacturing sector led with 6 financing rounds, exceeding 700 million RMB; the chip sector had 3 rounds, also exceeding 700 million RMB; and the artificial intelligence sector completed 3 rounds, surpassing 1 billion RMB [4][5]. Regional Distribution - The financing activities were concentrated in Jiangsu Province (10 rounds), Guangdong Province (5 rounds), Beijing (5 rounds), and Shanghai (4 rounds) [6][7]. Active Investors - Yida Capital was notably active, completing 2 investments, including Shanghai Yiyi Industrial Co. and Hangzhou HeWu System Technology Co. [8][9]. Notable Company Developments - Mosska completed a 30 million RMB A-round financing to enhance its offline store layout in the premium coffee sector [10]. - Shenzhen Carbon Cloud Peptide Technology secured strategic financing from Hanyu Pharmaceutical, focusing on AI drug discovery [12]. - Suzhou Zhongxi Bio received nearly 100 million RMB in A-round financing led by CITIC Capital, aimed at advancing its automated laboratory solutions [13]. - Hangzhou Quanzhen Medical Technology raised several million RMB in B-round financing, focusing on AI medical products [14]. - Tian Tong Vision completed a 500 million RMB D-round financing to optimize its shareholder structure and enhance its automotive intelligent driving systems [31].